Bloomberg Biosimilar Survey

Take part in the Biosimilars Survey – Bloomberg Intelligence

Bloomberg Intelligence have launched the Biosimilars Survey. This is your opportunity to have your voice heard. Take part in the survey here > All responders will receive a white paper and analysis of the results. That’s not all! All responders will also receive a 15% discount code off the delegate ticket price for World Biosimilar Congress USA 2015, where Bloomberg will be …

The Big Antibody Debate – Share your opinions and make a difference

In return for the chance to secure a 2-day delegate ticket* to Europe's leading Antibody and Next Gen Tech. Congress later this year; the 9th European Antibody Congress would like 3mins of your time. We`re canvassing the brightest stakeholders in the industry to hear what their thoughts are on the current state of play of the antibody and next generations …

Join the great Stem Cell debate

The 8th Annual World Stem Cells and Regenerative Medicine Congress, Europe's largest stem cell commercial conference for buyers and sellers, has commissioned an industry survey to learn about your critical scientific and business challenges in this industry. Tell us your challenges, your bottlenecks and also where you see opportunities in this growing industry so we can help you advance your …

Speaker Interview: find out what the experts are thinking

  In a recent interview in association with the European Antibody Congress, we posed 4 questions to our top speakers.  Below are the thoughts of one of our top Next Generation Antibody speakers who asked to remain anonymous;   1. How do you see antibody therapeutics developing over the next 5 years? Engineered and bispecific antibodies will arrive in the …

Released: Annual Asian Biopharmaceutical Industry Report

1600 industry professionals shared views about their opinions and interests in Asia’s biopharma industry. In the report, we discovered that partnering with local Asian and global Asian pharmas and biotechs continues to be the top area of interest and concern for the Asian biopharmaceutical industry. The report gave us a glimpse of the heartbeat of the biopharmaceutical industry as all …

World Orphan Drug Congress 2012–Industry Survey Report

In preparation for the World Orphan Drug Congress 2012, we collated a representative summary of the responses gained from our industry survey. We opened the survey up to a senior executive selection of the global orphan and rare disease market onwards of May 2012. What follows are viewpoints and opinions from approx. 375 international biopharmaceutical stakeholders from across Europe and …